A formal Phase 2 trial was completed in 2009, but over 15 years later, the results have never been published, another major red flag suggesting it failed to prove effective or safe
Emerging research suggests that DSIP may have analgesic properties, making it a potential option for pain management
Potency loss happens without visible precipitation or color change
GHK-Cu is generally regarded as one of the most well-tolerated peptides in skin care and regenerative research
Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies
It is found throughout the body, with particularly high concentrations in tissues with greater energy demands, including skeletal muscle, the heart and the liver